[1]
S. Rajaram, A. Murugan, and N. C.M, “Effect of Ascorbic Acid on dissolution stability of Rifampicin in market fixed dose combination products for Tuberculosis”, pt, vol. 5, no. 1, pp. 48-53, Jan. 2017.